港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

來凱醫藥-B

13.830

-0.200-1.43%

成交量：53.15萬

成交額：743.31萬

市值：61.68億

市盈率：-19.45

高：14.310

開：14.040

低：13.710

收：14.030

52周最高：23.500

52周最低：8.100

股本：4.46億

香港流通股本：4.46億

量比：0.64

換手率：0.12%

股息：- -

股息率：- -

每股收益(LYR):-0.711

淨資產收益率：-34.59%

總資產收益率：-19.92%

市淨率：7.62

市盈率(LYR):-19.45

市銷率: 1173.28

資料載入中...

總覽公司新聞資訊公告

來凱醫藥-B(02105)2025年實現收益約1.07億元研發費用按年增長16.17%

來凱醫藥-B(02105)2025年度授權收入推動營收增長虧損收窄資金狀況穩健

港股來凱醫藥-B午後一度升逾6%

每日经济新闻

BUZZ-體重控制藥物研究取得積極成果，Laekna 達到 6 周峯值

來凱醫藥-B盤中異動早盤快速拉升5.54%

來凱醫藥-B(02105)：LAE102美國I期SAD研究取得積極的頂線結果呈現令人鼓舞的增肌減脂趨勢

每日沽空追蹤 | 來凱醫藥-B 03月09日沽空量成交8.45萬股，沽空比例為3.86%

來凱醫藥-B（02105）發布2月股份變動月報表，股本維持穩定

每日沽空追蹤 | 來凱醫藥-B 03月03日沽空量成交4.45萬股，沽空比例為1.29%

來凱醫藥-B03月03日遭主力拋售301.6萬元

每日沽空追蹤 | 來凱醫藥-B 02月25日沽空量成交7.3萬股，沽空比例為6.53%

每日沽空追蹤 | 來凱醫藥-B 02月24日沽空量成交14.6萬股，沽空比例為9.11%

來凱醫藥(2105.HK)LAE002（Afuresertib）發《自然》雜誌子刊，預示一個爆款BIC誕生

來凱醫藥－Ｂ(02105)股價上升8.067%，現價港幣$14.2

阿斯达克财经

來凱醫藥-B盤中異動早盤股價大漲5.07%

每日沽空追蹤 | 來凱醫藥-B 02月16日沽空量成交12.95萬股，沽空比例為11.06%

每日沽空追蹤 | 來凱醫藥-B 02月13日沽空量成交11.6萬股，沽空比例為5.73%

來凱醫藥-B盤中異動股價大漲5.15%報12.860港元

每日沽空追蹤 | 來凱醫藥-B 02月10日沽空量成交4.75萬股，沽空比例為3.31%

來凱醫藥-B盤中異動股價大漲5.11%報12.950港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02105/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02105","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"來凱醫藥-B","latestPrice":13.83,"timestamp":1774328427091,"preClose":14.03,"halted":0,"volume":531500,"delay":0,"changeRate":-0.014255167498218054,"floatShares":446000000,"shares":446000000,"eps":-0.711066,"marketStatus":"交易中","change":-0.2,"latestTime":"03-24 13:01:36","open":14.04,"high":14.31,"low":13.71,"amount":7433115,"amplitude":0.042766,"askPrice":13.88,"askSize":3500,"bidPrice":13.79,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.569,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774339800000},"marketStatusCode":2,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":14.03,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0.643028,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02105\",,,,,undefined,":{"symbol":"02105","floatShares":446000000,"roa":"-19.92%","roe":"-34.59%","lyrEps":-0.711066,"volumeRatio":0.643028,"shares":446000000,"dividePrice":0,"high":14.31,"amplitude":0.042766,"preClose":14.03,"low":13.71,"week52Low":8.1,"pbRate":"7.62","psRate":"1173.28","week52High":23.5,"institutionHeld":0,"latestPrice":13.83,"committee":-0.555556,"eps":-0.711066,"divideRate":0,"volume":531500,"delay":0,"ttmEps":-0.569,"open":14.04,"prevYearClose":13.57,"prevWeekClose":15,"prevMonthClose":13.3,"prevQuarterClose":13.57,"fiveDayClose":14.77,"twentyDayClose":13.59,"sixtyDayClose":14.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02105\",params:#limit:5,,,undefined,":[{"date":"2026-03-18","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773797400000,"name":null,"time":"","dateTimestamp":1773763200000,"actualEps":null},{"date":"2025-08-13","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755048600000,"name":null,"time":"","dateTimestamp":1755014400000,"actualEps":null},{"date":"2025-03-24","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-16","symbol":"02105","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723771800000,"name":null,"time":"盤後","dateTimestamp":1723737600000,"actualEps":null},{"date":"2024-03-26","symbol":"02105","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711416600000,"name":null,"time":"","dateTimestamp":1711382400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02105\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02105\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1754496000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02105\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02105","date":"2026-03-23","current":-24.3058,"percent":0.219585,"low":-30.832985,"twenty":-21.879437,"median":-11.070836,"eighty":-5.54113,"high":-1.640852,"avg":-13.16359,"sd":7.961791,"marketCap":5867956585},"quantilePoints":[{"date":"2023-06-30","current":-7.785551,"twenty":-6.73679,"median":-5.163648,"eighty":-3.590506,"marketCap":6577091901},{"date":"2023-07-07","current":-6.912426,"twenty":-7.480081,"median":-7.023469,"eighty":-6.753459,"marketCap":5828099229},{"date":"2023-07-14","current":-6.415246,"twenty":-7.354402,"median":-6.80281,"eighty":-6.620389,"marketCap":5484810921},{"date":"2023-07-21","current":-6.50021,"twenty":-7.00126,"median":-6.637911,"eighty":-6.415921,"marketCap":5531622963},{"date":"2023-07-28","current":-6.387862,"twenty":-6.910347,"median":-6.626959,"eighty":-6.393338,"marketCap":5430196872},{"date":"2023-08-04","current":-6.872048,"twenty":-6.916775,"median":-6.645885,"eighty":-6.415921,"marketCap":5851505250},{"date":"2023-08-11","current":-8.062915,"twenty":-7.354402,"median":-6.732662,"eighty":-6.423028,"marketCap":6826756125},{"date":"2023-08-18","current":-6.496848,"twenty":-7.428921,"median":-6.729682,"eighty":-6.45189,"marketCap":5461404900},{"date":"2023-08-25","current":-8.440637,"twenty":-7.525288,"median":-6.804775,"eighty":-6.49752,"marketCap":6327427677},{"date":"2023-09-01","current":-9.089804,"twenty":-8.007442,"median":-6.902032,"eighty":-6.501491,"marketCap":6842360139},{"date":"2023-09-08","current":-6.586545,"twenty":-8.136633,"median":-6.907229,"eighty":-6.507456,"marketCap":4899660396},{"date":"2023-09-15","current":-5.932237,"twenty":-8.007442,"median":-6.869978,"eighty":-6.423028,"marketCap":4447143990},{"date":"2023-09-22","current":-6.606383,"twenty":-7.784235,"median":-6.883282,"eighty":-6.45189,"marketCap":4930868424},{"date":"2023-09-29","current":-7.14814,"twenty":-7.744431,"median":-6.894516,"eighty":-6.45189,"marketCap":5344374795},{"date":"2023-10-06","current":-7.631816,"twenty":-7.631816,"median":-6.912426,"eighty":-6.496848,"marketCap":5703267117},{"date":"2023-10-13","current":-8.856112,"twenty":-8.155063,"median":-6.923868,"eighty":-6.50021,"marketCap":6608299929},{"date":"2023-10-20","current":-8.199572,"twenty":-8.313082,"median":-7.000277,"eighty":-6.506614,"marketCap":6108971481},{"date":"2023-10-27","current":-9.816471,"twenty":-8.453817,"median":-7.029823,"eighty":-6.509983,"marketCap":7310480559},{"date":"2023-11-03","current":-11.65035,"twenty":-8.539495,"median":-7.190868,"eighty":-6.562195,"marketCap":8699237805},{"date":"2023-11-10","current":-10.973476,"twenty":-8.805599,"median":-7.285091,"eighty":-6.584244,"marketCap":8192107350},{"date":"2023-11-17","current":-11.729885,"twenty":-9.08956,"median":-7.4166,"eighty":-6.600627,"marketCap":8835772927},{"date":"2023-11-24","current":-11.685472,"twenty":-9.394133,"median":-7.490817,"eighty":-6.605936,"marketCap":8874782962},{"date":"2023-12-01","current":-9.84176,"twenty":-10.15546,"median":-7.577915,"eighty":-6.610422,"marketCap":7505530734},{"date":"2023-12-08","current":-7.796477,"twenty":-9.900606,"median":-7.778973,"eighty":-6.615093,"marketCap":5921723313},{"date":"2023-12-15","current":-9.518573,"twenty":-9.821529,"median":-7.782262,"eighty":-6.63353,"marketCap":7271470524},{"date":"2023-12-22","current":-9.095699,"twenty":-9.838318,"median":-7.864399,"eighty":-6.64429,"marketCap":6943786230},{"date":"2023-12-29","current":-10.114857,"twenty":-10.007865,"median":-8.108989,"eighty":-6.673018,"marketCap":7762996965},{"date":"2024-01-05","current":-7.064143,"twenty":-9.846254,"median":-7.963657,"eighty":-6.71691,"marketCap":5383384830},{"date":"2024-01-12","current":-6.507833,"twenty":-9.8409,"median":-7.785551,"eighty":-6.71691,"marketCap":4962076452},{"date":"2024-01-19","current":-6.147909,"twenty":-9.833261,"median":-7.674627,"eighty":-6.639506,"marketCap":4681204200},{"date":"2024-01-26","current":-4.037471,"twenty":-9.789285,"median":-7.606263,"eighty":-6.604594,"marketCap":3062287747},{"date":"2024-02-02","current":-1.910591,"twenty":-9.668744,"median":-7.523229,"eighty":-6.508431,"marketCap":1447272298},{"date":"2024-02-09","current":-1.972972,"twenty":-9.600955,"median":-7.449769,"eighty":-6.45189,"marketCap":1501886347},{"date":"2024-02-16","current":-2.11088,"twenty":-9.539168,"median":-7.4166,"eighty":-6.417948,"marketCap":1607213442},{"date":"2024-02-23","current":-1.782124,"twenty":-9.334553,"median":-7.285091,"eighty":-6.285716,"marketCap":1349747211},{"date":"2024-03-01","current":-3.73704,"twenty":-9.184661,"median":-7.220535,"eighty":-6.16588,"marketCap":2832128541},{"date":"2024-03-08","current":-3.812556,"twenty":-9.158571,"median":-7.14814,"eighty":-5.783471,"marketCap":2890643593},{"date":"2024-03-15","current":-3.774736,"twenty":-9.108268,"median":-7.054895,"eighty":-5.122231,"marketCap":2859435565},{"date":"2024-03-22","current":-3.314294,"twenty":-9.090983,"median":-7.029823,"eighty":-4.16949,"marketCap":2508345250},{"date":"2024-03-28","current":-5.557677,"twenty":-9.089621,"median":-7.000277,"eighty":-4.108477,"marketCap":2219670991},{"date":"2024-04-05","current":-4.994454,"twenty":-9.061533,"median":-6.958518,"eighty":-4.159233,"marketCap":1993412788},{"date":"2024-04-12","current":-4.698569,"twenty":-8.939101,"median":-6.914215,"eighty":-4.187247,"marketCap":1876382683},{"date":"2024-04-19","current":-5.074098,"twenty":-8.895252,"median":-6.907229,"eighty":-4.270544,"marketCap":2024620816},{"date":"2024-04-26","current":-6.049449,"twenty":-8.886537,"median":-6.872048,"eighty":-4.439166,"marketCap":2410820163},{"date":"2024-05-03","current":-6.122202,"twenty":-8.8768,"median":-6.815159,"eighty":-4.698569,"marketCap":2438127187},{"date":"2024-05-10","current":-6.43996,"twenty":-8.86224,"median":-6.755587,"eighty":-4.994454,"marketCap":2570761306},{"date":"2024-05-17","current":-7.203002,"twenty":-8.857338,"median":-6.782134,"eighty":-5.0499,"marketCap":2871138576},{"date":"2024-05-24","current":-4.794357,"twenty":-8.851703,"median":-6.739573,"eighty":-4.885401,"marketCap":2754108471},{"date":"2024-05-31","current":-4.572395,"twenty":-8.804497,"median":-6.721699,"eighty":-4.757241,"marketCap":2629276359},{"date":"2024-06-07","current":-4.421848,"twenty":-8.685949,"median":-6.645885,"eighty":-4.615745,"marketCap":2539553278},{"date":"2024-06-14","current":-3.882014,"twenty":-8.64394,"median":-6.616008,"eighty":-4.537135,"marketCap":2227472998},{"date":"2024-06-21","current":-3.862906,"twenty":-8.598267,"median":-6.605265,"eighty":-4.402835,"marketCap":2211868984},{"date":"2024-06-28","current":-3.550986,"twenty":-8.56584,"median":-6.575038,"eighty":-4.108477,"marketCap":2032422823},{"date":"2024-07-05","current":-3.292704,"twenty":-8.553381,"median":-6.507833,"eighty":-3.906941,"marketCap":1884184690},{"date":"2024-07-12","current":-3.669077,"twenty":-8.541472,"median":-6.498529,"eighty":-3.863311,"marketCap":2102640886},{"date":"2024-07-19","current":-2.927038,"twenty":-8.530589,"median":-6.44065,"eighty":-3.81922,"marketCap":1677431505},{"date":"2024-07-26","current":-2.773786,"twenty":-8.516747,"median":-6.41868,"eighty":-3.760814,"marketCap":1595510431},{"date":"2024-08-02","current":-3.12148,"twenty":-8.510893,"median":-6.387862,"eighty":-3.652511,"marketCap":1794461610},{"date":"2024-08-09","current":-2.9997,"twenty":-8.480176,"median":-6.325017,"eighty":-3.53511,"marketCap":1735946557},{"date":"2024-08-16","current":-3.214159,"twenty":-8.413826,"median":-6.28512,"eighty":-3.427,"marketCap":1860778669},{"date":"2024-08-23","current":-6.604067,"twenty":-8.372166,"median":-6.272718,"eighty":-3.478589,"marketCap":2129947911},{"date":"2024-08-30","current":-6.163541,"twenty":-8.347233,"median":-6.28512,"eighty":-3.497821,"marketCap":2001214795},{"date":"2024-09-06","current":-5.314921,"twenty":-8.300967,"median":-6.252611,"eighty":-3.516857,"marketCap":1726510663},{"date":"2024-09-13","current":-5.032211,"twenty":-8.277822,"median":-6.194778,"eighty":-3.53511,"marketCap":1630395636},{"date":"2024-09-20","current":-5.111432,"twenty":-8.256206,"median":-6.170373,"eighty":-3.56099,"marketCap":1665993794},{"date":"2024-09-27","current":-6.057967,"twenty":-8.195708,"median":-6.135055,"eighty":-3.605108,"marketCap":1986377216},{"date":"2024-10-04","current":-7.03444,"twenty":-8.180254,"median":-6.166957,"eighty":-3.621517,"marketCap":2296081191},{"date":"2024-10-10","current":-6.311883,"twenty":-8.160101,"median":-6.193894,"eighty":-3.641637,"marketCap":2046894085},{"date":"2024-10-18","current":-9.026405,"twenty":-8.160101,"median":-6.241014,"eighty":-3.658355,"marketCap":2911929324},{"date":"2024-10-25","current":-10.329157,"twenty":-8.288852,"median":-6.25781,"eighty":-3.667517,"marketCap":3331987588},{"date":"2024-11-01","current":-10.068556,"twenty":-8.453817,"median":-6.28512,"eighty":-3.723447,"marketCap":3250111825},{"date":"2024-11-08","current":-11.890039,"twenty":-8.539495,"median":-6.303819,"eighty":-3.748634,"marketCap":3809002906},{"date":"2024-11-15","current":-12.473246,"twenty":-8.638855,"median":-6.337113,"eighty":-3.770095,"marketCap":3965634801},{"date":"2024-11-22","current":-15.548537,"twenty":-8.857338,"median":-6.401271,"eighty":-3.792036,"marketCap":4941024330},{"date":"2024-11-29","current":-16.918042,"twenty":-8.907392,"median":-6.418623,"eighty":-3.798946,"marketCap":5372620800},{"date":"2024-12-06","current":-17.028741,"twenty":-9.08956,"median":-6.440305,"eighty":-3.809963,"marketCap":5395037855},{"date":"2024-12-13","current":-14.037501,"twenty":-9.184661,"median":-6.496848,"eighty":-3.825885,"marketCap":4438576850},{"date":"2024-12-20","current":-10.693671,"twenty":-9.519989,"median":-6.507224,"eighty":-3.843767,"marketCap":3366294395},{"date":"2024-12-27","current":-10.761363,"twenty":-9.613258,"median":-6.510825,"eighty":-3.853605,"marketCap":3384975274},{"date":"2025-01-03","current":-12.815569,"twenty":-9.789285,"median":-6.563121,"eighty":-3.862906,"marketCap":4035069864},{"date":"2025-01-10","current":-14.889249,"twenty":-9.925093,"median":-6.595306,"eighty":-3.863109,"marketCap":4670219750},{"date":"2025-01-17","current":-11.842286,"twenty":-10.213871,"median":-6.606383,"eighty":-3.864484,"marketCap":3717494921},{"date":"2025-01-24","current":-10.786847,"twenty":-10.358151,"median":-6.624251,"eighty":-3.867614,"marketCap":3407392329},{"date":"2025-01-28","current":-10.88357,"twenty":-10.395234,"median":-6.635203,"eighty":-3.869357,"marketCap":3455962615},{"date":"2025-02-07","current":-10.247352,"twenty":-10.395234,"median":-6.668158,"eighty":-3.877648,"marketCap":3235528242},{"date":"2025-02-14","current":-10.714001,"twenty":-10.679993,"median":-6.721699,"eighty":-3.919404,"marketCap":3381239099},{"date":"2025-02-21","current":-14.934496,"twenty":-10.737429,"median":-6.739573,"eighty":-3.995096,"marketCap":4729998562},{"date":"2025-02-28","current":-14.81818,"twenty":-10.833722,"median":-6.801774,"eighty":-4.034059,"marketCap":4677692101},{"date":"2025-03-07","current":-17.375919,"twenty":-11.045086,"median":-6.869978,"eighty":-4.108477,"marketCap":5507123129},{"date":"2025-03-14","current":-16.002657,"twenty":-11.141514,"median":-6.898274,"eighty":-4.166071,"marketCap":5073726736},{"date":"2025-03-21","current":-15.584553,"twenty":-11.292034,"median":-6.914215,"eighty":-4.215924,"marketCap":4939224407},{"date":"2025-03-28","current":-19.960729,"twenty":-11.418322,"median":-6.958518,"eighty":-4.322429,"marketCap":5432399613},{"date":"2025-04-03","current":-17.71685,"twenty":-11.522026,"median":-7.011873,"eighty":-4.393328,"marketCap":4812194430},{"date":"2025-04-11","current":-14.733536,"twenty":-11.702518,"median":-7.03444,"eighty":-4.445369,"marketCap":3975291051},{"date":"2025-04-17","current":-15.831036,"twenty":-11.83884,"median":-7.042573,"eighty":-4.481028,"marketCap":4281657466},{"date":"2025-04-25","current":-18.85387,"twenty":-11.890039,"median":-7.064143,"eighty":-4.482534,"marketCap":5103616142},{"date":"2025-05-02","current":-20.273816,"twenty":-12.024603,"median":-7.138152,"eighty":-4.483904,"marketCap":5499650777},{"date":"2025-05-09","current":-20.37867,"twenty":-12.272607,"median":-7.171338,"eighty":-4.537135,"marketCap":5566901942},{"date":"2025-05-16","current":-19.209634,"twenty":-12.535336,"median":-7.205238,"eighty":-4.575802,"marketCap":5290424932},{"date":"2025-05-23","current":-24.021586,"twenty":-12.71305,"median":-7.273665,"eighty":-4.590948,"marketCap":6635448220},{"date":"2025-05-30","current":-24.266566,"twenty":-12.811921,"median":-7.298393,"eighty":-4.611692,"marketCap":6732588791},{"date":"2025-06-06","current":-26.139049,"twenty":-13.04892,"median":-7.396066,"eighty":-4.640938,"marketCap":7270598106},{"date":"2025-06-13","current":-29.74055,"twenty":-13.19671,"median":-7.470293,"eighty":-4.681154,"marketCap":8275629397},{"date":"2025-06-20","current":-28.050034,"twenty":-13.86335,"median":-7.533906,"eighty":-4.700982,"marketCap":7789926543},{"date":"2025-06-27","current":-24.148232,"twenty":-14.651862,"median":-7.597268,"eighty":-4.71884,"marketCap":6725116440},{"date":"2025-07-04","current":-23.234874,"twenty":-14.895898,"median":-7.634748,"eighty":-4.738772,"marketCap":6471056485},{"date":"2025-07-11","current":-22.291445,"twenty":-15.089879,"median":-7.696392,"eighty":-4.760215,"marketCap":6202051828},{"date":"2025-07-18","current":-26.31753,"twenty":-15.471722,"median":-7.782262,"eighty":-4.775945,"marketCap":7316474020},{"date":"2025-07-25","current":-25.476909,"twenty":-15.613487,"median":-7.864399,"eighty":-4.786942,"marketCap":7108532126},{"date":"2025-08-01","current":-24.329935,"twenty":-15.664049,"median":-8.108989,"eighty":-4.797184,"marketCap":6746559201},{"date":"2025-08-08","current":-25.903798,"twenty":-15.966112,"median":-8.199572,"eighty":-4.803824,"marketCap":7200950746},{"date":"2025-08-15","current":-26.404653,"twenty":-16.351868,"median":-8.297938,"eighty":-4.809409,"marketCap":6923694888},{"date":"2025-08-22","current":-24.957996,"twenty":-16.76437,"median":-8.37361,"eighty":-4.821672,"marketCap":6523837408},{"date":"2025-08-29","current":-23.625619,"twenty":-17.081215,"median":-8.510167,"eighty":-4.847599,"marketCap":6205046052},{"date":"2025-09-05","current":-24.661552,"twenty":-17.4013,"median":-8.538507,"eighty":-4.876556,"marketCap":6470705516},{"date":"2025-09-12","current":-20.300804,"twenty":-17.709582,"median":-8.5673,"eighty":-4.894937,"marketCap":5336119539},{"date":"2025-09-19","current":-22.387755,"twenty":-18.502396,"median":-8.659194,"eighty":-4.936492,"marketCap":5880503891},{"date":"2025-09-26","current":-23.755076,"twenty":-18.883269,"median":-8.853357,"eighty":-5.007141,"marketCap":6223463577},{"date":"2025-10-03","current":-26.75639,"twenty":-19.317505,"median":-8.86952,"eighty":-5.027379,"marketCap":7026491136},{"date":"2025-10-10","current":-24.099943,"twenty":-19.58973,"median":-8.892896,"eighty":-5.032211,"marketCap":6319659587},{"date":"2025-10-17","current":-21.756329,"twenty":-19.863851,"median":-8.951685,"eighty":-5.039347,"marketCap":5700659177},{"date":"2025-10-24","current":-19.051807,"twenty":-20.078316,"median":-9.089652,"eighty":-5.055065,"marketCap":4993827628},{"date":"2025-10-31","current":-18.736648,"twenty":-20.048899,"median":-9.127121,"eighty":-5.062023,"marketCap":4918543795},{"date":"2025-11-07","current":-16.723664,"twenty":-19.976892,"median":-9.288548,"eighty":-5.072031,"marketCap":4387374524},{"date":"2025-11-14","current":-21.334357,"twenty":-19.976892,"median":-9.450099,"eighty":-5.103965,"marketCap":5612828038},{"date":"2025-11-21","current":-24.191268,"twenty":-20.149,"median":-9.60082,"eighty":-5.127222,"marketCap":6361483939},{"date":"2025-11-28","current":-26.084626,"twenty":-20.359324,"median":-9.675041,"eighty":-5.135712,"marketCap":6884288339},{"date":"2025-12-05","current":-26.466998,"twenty":-20.455357,"median":-9.837458,"eighty":-5.145701,"marketCap":6997214089},{"date":"2025-12-12","current":-24.949582,"twenty":-21.347937,"median":-9.89595,"eighty":-5.163276,"marketCap":6608247616},{"date":"2025-12-19","current":-24.323785,"twenty":-21.641075,"median":-10.068556,"eighty":-5.198656,"marketCap":6457679948},{"date":"2025-12-24","current":-21.98676,"twenty":-21.77214,"median":-10.125423,"eighty":-5.211333,"marketCap":5855409280},{"date":"2026-01-02","current":-21.259193,"twenty":-21.755726,"median":-10.240347,"eighty":-5.219085,"marketCap":5683929436},{"date":"2026-01-09","current":-20.81628,"twenty":-21.755726,"median":-10.329157,"eighty":-5.237411,"marketCap":5579368556},{"date":"2026-01-16","current":-22.553102,"twenty":-21.77741,"median":-10.348222,"eighty":-5.302498,"marketCap":6064531040},{"date":"2026-01-23","current":-24.816667,"twenty":-21.782791,"median":-10.364083,"eighty":-5.307592,"marketCap":6666801708},{"date":"2026-01-30","current":-21.232192,"twenty":-21.93483,"median":-10.54642,"eighty":-5.31773,"marketCap":5729936224},{"date":"2026-02-06","current":-19.168838,"twenty":-21.847156,"median":-10.680397,"eighty":-5.331073,"marketCap":5186219648},{"date":"2026-02-13","current":-19.151587,"twenty":-21.790077,"median":-10.7243,"eighty":-5.344782,"marketCap":5211314259},{"date":"2026-02-20","current":-20.225911,"twenty":-21.786448,"median":-10.738136,"eighty":-5.355348,"marketCap":5495719852},{"date":"2026-02-27","current":-20.250109,"twenty":-21.782736,"median":-10.786847,"eighty":-5.38165,"marketCap":5562638816},{"date":"2026-03-06","current":-19.984902,"twenty":-21.771543,"median":-10.928523,"eighty":-5.410462,"marketCap":5445530630},{"date":"2026-03-13","current":-22.811571,"twenty":-21.771543,"median":-11.041852,"eighty":-5.454036,"marketCap":6244375753},{"date":"2026-03-20","current":-23.005636,"twenty":-21.897901,"median":-11.062683,"eighty":-5.524583,"marketCap":6273652800},{"date":"2026-03-23","current":-21.478278,"twenty":-21.879437,"median":-11.070836,"eighty":-5.54113,"marketCap":5867956585}],"updateTime":1774328496383},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02105\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620232095","title":"來凱醫藥-B(02105)2025年實現收益約1.07億元 研發費用按年增長16.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232095","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620232095?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 18:55","pubTimestamp":1773831316,"startTime":"0","endTime":"0","summary":"智通财经APP讯，来凯医药-B 公布2025年业绩，实现收益约1.07亿元，毛利8641.9万元，研发费用约2.5亿元，同比增长16.17%;净亏损约2.29亿元，同比收窄9.82%。公告称，2025年的收益来源于与齐鲁制药进行的LAE002的对外授权交易。研发费用增长主要是由于ActRII产品组合的相关费用增加，及以权益结算的股份支付的付款开支增加。截至2025年12月31日，公司已针对LAE102、LAE103、LAE002、LAE001及LAE005启动七项临床试验，以解决肥胖症及癌症领域未被满足的医疗需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1132876590","title":"來凱醫藥-B(02105)2025年度授權收入推動營收增長 虧損收窄 資金狀況穩健","url":"https://stock-news.laohu8.com/highlight/detail?id=1132876590","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132876590?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 18:49","pubTimestamp":1773830953,"startTime":"0","endTime":"0","summary":"来凯医药有限公司截至2025年12月31日止年度录得收入人民币106,719千元，主要来自与齐鲁制药签订对外授权交易所产生的许可收入。销售成本为人民币20,300千元，带动报告期内实现毛利人民币86,419千元。研发投入持续保持高水平，年内研究费用达到人民币249,901千元，相比2024年的人民币215,115千元有所上升；行政开支亦自上一年度的人民币74,115千元增至人民币106,478千元，主要受以权益结算的股份支付及相关开支增加所致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"2619653001","title":"港股來凱醫藥-B午後一度升逾6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619653001","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619653001?lang=zh_tw&edition=fundamental","pubTime":"2026-03-13 14:25","pubTimestamp":1773383139,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月13日，来凯医药-B(02105.HK)午后一度涨超6%，截至发稿涨4.87%，报14.63港元，成交额2160.63万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603133671387714.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603133671387714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK4588","VXUS","BK4585","02105"],"gpt_icon":0},{"id":"2618498380","title":"BUZZ-體重控制藥物研究取得積極成果，Laekna 達到 6 周峯值","url":"https://stock-news.laohu8.com/highlight/detail?id=2618498380","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618498380?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 12:49","pubTimestamp":1773118163,"startTime":"0","endTime":"0","summary":"** LAE102 是一种有希望实现高质量体重控制的候选药物 - Co ** 该集团正与潜在合作伙伴积极讨论，以加速 LAE102 的全球开发和商业化。** 年初至今，股价上涨 5.8%，恒生生物科技指数 .HSBIO 上涨 4.1%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nL4T3ZY0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4JS1V06.HKD","LU2756315664.SGD","IE00BKPKM429.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU1093756168.USD","SG9999013999.USD","LU1551013342.USD","LU2360106947.USD","LU0683600562.USD","LU2168564222.USD","LU2896262040.SGD","LLYX","SG9999014898.SGD","IE0009355771.USD","LU2237443978.SGD","LU1868836914.USD","LU2602419157.SGD","LU1814569148.SGD","LU0354030511.USD","LU2168564495.EUR","LU0417517546.SGD","IE00B1XK9C88.USD","LU2471134952.CNY","IE00BWXC8680.SGD","BK4516","LU0708995401.HKD","LLII","LU0823416689.USD","LU1291159041.SGD","BK1161","SG9999015945.SGD","LU1868836757.USD","IE0001KFT4U8.USD","LU1127390331.HKD","LU2552382132.HKD","LU2552382215.SGD","IE00B7KXQ091.USD","LU0471298777.SGD","LU1548497426.USD","LU0787776722.HKD","LU2087625088.SGD","LU2456880835.USD","IE00B1BXHZ80.USD","LU2491050154.USD","LU2211815571.USD","LU2213496289.HKD","SGXZ51526630.SGD","LU2106854487.HKD","02105","LU0238689110.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","LU0786609619.USD","SG9999014906.USD","LU1989771016.USD","IE00BJJMRY28.SGD","LU0289739699.SGD","LU0471298694.HKD","LU2264538146.SGD","LU0353189680.USD","LU2357305700.SGD","BK4599","ELIS","SG9999015952.SGD","LU0354030438.USD","LU0432979614.USD","LU2471134796.USD","LU1280957306.USD","LU0058720904.USD","LU0203202063.USD","LU2089284900.SGD","LU2089984988.USD","GB00BDT5M118.USD","BK4585","SG9999014880.SGD","LU1093756325.SGD","LU0266013472.USD","LU1267930730.SGD","LU1323610961.USD","LU2491050071.SGD","LU0640476718.USD","LU0320765059.SGD","IE0005OL40V9.USD","LU2471134879.HKD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4533","LU0256863811.USD","LU0385154629.USD","LU0882574139.USD","LU1061106388.HKD","SG9999015986.USD","IE00BJLML261.HKD","LU1804176565.USD","LU0225283273.USD","LU2237438978.USD","LU2237443382.USD","BK4588","LU0964807845.USD","LU1988902786.USD","LU2361044865.SGD","LU2471134523.USD","SG9999001176.SGD","LU2168564065.EUR","LU1232071149.USD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0889565916.HKD","LU0234572021.USD","LU1366192091.USD","IE00B4R5TH58.HKD","LU0353189763.USD","LU2089283258.USD","LU1145028129.USD","LU2746668974.SGD","SG9999018857.SGD","LU0097036916.USD","LLYZ","LU2237443549.SGD","LU2271345857.HKD","LU2168564149.EUR","SGXZ99366536.SGD","LU1917777945.USD","LU0061475181.USD","LU1868837136.USD","LU1035775433.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU2417539215.USD","LU0114720955.EUR","LU2552382058.USD","IE00BFSS7M15.SGD","LU0820561909.HKD","BK4534","LU2324357040.USD","ELIL","LU2168563687.JPY","LU0122379950.USD","LU1868836591.USD","LU2468319806.SGD","IE00BK4W5M84.HKD","LU1069344957.HKD","LU2461242641.AUD","LU0106261372.USD","LU2111349929.HKD","LU0109391861.USD","IE00BFSS8Q28.SGD","LU1623119135.USD","LU0320765992.SGD","LU2265009873.SGD","SG9999001176.USD","LU0158827948.USD","LU2023250504.SGD","LU0203201768.USD","LU1057294990.SGD","LU2746668461.USD","LU0689472784.USD","IE0004445015.USD","IE0004445239.USD","LU2491049909.HKD","LU0210536198.USD","LU2756315318.SGD","BK4581","LU2108987350.USD","LU2237443895.HKD","SG9999014914.USD","LU1064131342.USD","LU1868837300.USD","LU1983299246.USD","LU2237443465.HKD","IE00BKDWB100.SGD","LU0109394709.USD","IE0002141913.USD","SG9999017495.SGD","LU2462157665.USD","IE00B775H168.HKD","LU0456855351.SGD","LU2236285917.USD","LU1720051017.SGD","LU2361044949.HKD","LU2750360641.GBP","LU2028103732.USD","LU0820562030.AUD","LU1712237335.SGD","LU0316494557.USD","LU1720051108.HKD","LU0158827781.USD","BK4007","LU0823434583.USD","LU2023251221.USD","SG9999018865.SGD","LU1974910355.USD","LU2361045086.USD","LU0323591593.USD","LU1551013425.SGD","IE00BJJMRX11.SGD","IE00BFTCPJ56.SGD","SG9999015978.USD","LU0823434740.USD","LU0882574055.USD","LU2750360997.AUD","LU0006306889.USD","LU1629891620.HKD","LU0094547139.USD","LU0466842654.USD","LU0943347566.SGD","LU0820561818.USD","LU0079474960.USD","LU2063271972.USD","SGXZ81514606.USD","LU0198837287.USD","LU2023250330.USD","IE00BN29S564.USD","LU2237443622.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2618660255","title":"來凱醫藥-B盤中異動 早盤快速拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618660255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618660255?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 09:30","pubTimestamp":1773106212,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时30分，来凯医药-B股票出现波动，股价急速拉升5.54%。截至发稿，该股报14.280港元/股，成交量3.75万股，换手率0.01%，振幅4.88%。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，来凯医药-B、科伦博泰生物-B、康方生物涨幅较大，振幅较大的相关个股有乐普生物-B、宜明昂科-B、来凯医药-B，振幅分别为5.17%、5.00%、4.88%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009301295466820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009301295466820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2618605963","title":"來凱醫藥-B(02105)：LAE102美國I期SAD研究取得積極的頂線結果呈現令人鼓舞的增肌減脂趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2618605963","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618605963?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 08:15","pubTimestamp":1773101743,"startTime":"0","endTime":"0","summary":"智通财经APP讯，来凯医药-B 发布公告，集团与礼来公司合作，在美国成功完成LAE102的I期单剂量递增研究。安全性特征与先前研究结果一致，美国SAD研究进一步证实LAE102具有良好的耐受性，且未报告任何严重不良事件。疗效方面，美国SAD研究显示：单次给药后，受试者身体组成部分呈现令人鼓舞的改善趋势，观察到与剂量相关的增肌减脂效果。上述积极结果进一步支持LAE102作为心血管代谢疾病治疗的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"来凯医药-B(02105)：LAE102美国I期SAD研究取得积极的顶线结果呈现令人鼓舞的增肌减脂趋势","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2618602582","title":"每日沽空追蹤 | 來凱醫藥-B 03月09日沽空量成交8.45萬股，沽空比例為3.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618602582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618602582?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 16:30","pubTimestamp":1773045028,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间03月09日，涨3.92%，卖空量成交8.45万股，较上一交易日增加1.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163344a6b1c769&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163344a6b1c769&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1154854816","title":"來凱醫藥-B（02105）發布2月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1154854816","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154854816?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 17:17","pubTimestamp":1772702226,"startTime":"0","endTime":"0","summary":"来凯医药有限公司于2026年3月5日提交截至2026年2月28日的股份变动月报表。报告显示，公司法定股本维持5,000,000,000股，每股面值0.00001美元，总额50,000美元。截至2026年2月底，普通股已发行股份总数为446,466,350股，较上月底无增加或减少。根据公司披露，本月内未发生股份发行、购回或注销行为，库存股数量保持为0。公司同时表示，本月所有股份及相关操作均获得董事会正式授权，并已遵守适用上市规则与相关法律规定。本次月报由联席公司秘书柯晨煜签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7babad1b4c042890cc8c6c387e110b44","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"2616378020","title":"每日沽空追蹤 | 來凱醫藥-B 03月03日沽空量成交4.45萬股，沽空比例為1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616378020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616378020?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 16:30","pubTimestamp":1772526628,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间03月03日，跌11.08%，卖空量成交4.45万股，较上一交易日减少85.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163339a445cb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163339a445cb75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2616780053","title":"來凱醫藥-B03月03日遭主力拋售301.6萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616780053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616780053?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 16:15","pubTimestamp":1772525721,"startTime":"0","endTime":"0","summary":"03月03日, 来凯医药-B股价跌11.08%，报收11.24元，成交金额4018.5万元，换手率0.77%，振幅12.10%，量比2.39。来凯医药-B今日主力资金净流出301.6万元，上一交易日主力净流出40.3万元。该股近5个交易日下跌17.37%，主力资金累计净流出94.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出72.3万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161617a69c95ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303161617a69c95ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2614039243","title":"每日沽空追蹤 | 來凱醫藥-B 02月25日沽空量成交7.3萬股，沽空比例為6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614039243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614039243?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 16:30","pubTimestamp":1772008230,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月25日，跌1.4%，卖空量成交7.3万股，较上一交易日减少60%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163348a71d5a10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163348a71d5a10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2613796978","title":"每日沽空追蹤 | 來凱醫藥-B 02月24日沽空量成交14.6萬股，沽空比例為9.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796978","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796978?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 16:30","pubTimestamp":1771921826,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月24日，跌3.96%，卖空量成交14.6万股，较上一交易日增加0.34%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163354a4c23533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163354a4c23533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2613796922","title":"來凱醫藥(2105.HK)LAE002（Afuresertib）發《自然》雜誌子刊，預示一個爆款BIC誕生","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796922","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796922?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 08:43","pubTimestamp":1771893792,"startTime":"0","endTime":"0","summary":"目前，来凯医药Afuresertib关键III期临床进行中，并有望在2026上半年读出数据并递交国内一类新药申请。直接上结论，Afuresertib在多种突变人群中治疗潜力突出，具备广谱治疗药物特征。基于AKT抑制剂Capivasertib较PI3Kα 抑制剂Alpelisib安全性优势，来凯医药Afuresertib有望在AKT抑制剂赛道提升患者耐受性上更上一层楼，进一步加固同类最佳药物潜力。聚焦Afuresertib的1b期安全性数据，展现了较佳的安全性和耐受性。从给药周期和剂量角度，进一步凸显了Afuresertib的安全优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224084331a7177018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224084331a7177018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2613207404","title":"來凱醫藥－Ｂ(02105)股價上升8.067%，現價港幣$14.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2613207404","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613207404?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 15:55","pubTimestamp":1771833300,"startTime":"0","endTime":"0","summary":"[上升股]来凯医药－Ｂ(02105) 股价在下午03:55比前收市价上升8.067%，现股价为港币$14.2。至目前为止，今日最高价为$14.2，而最低价为$13.25。总成交量为204.862万股，总成交金额为港币$2.832千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2602238233/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2602238233/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2612548992","title":"來凱醫藥-B盤中異動 早盤股價大漲5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612548992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612548992?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 09:57","pubTimestamp":1771552639,"startTime":"0","endTime":"0","summary":"2026年02月20日早盘09时57分，来凯医药-B股票出现异动，股价大幅拉升5.07%。截至发稿，该股报13.470港元/股，成交量29.6万股，换手率0.07%，振幅8.74%。来凯医药-B股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，永泰生物-B、来凯医药-B、百济神州涨幅较大，振幅较大的相关个股有来凯医药-B、中慧生物-B、诺诚健华，振幅分别为8.74%、8.44%、7.72%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220095719a4b4f762&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220095719a4b4f762&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2612343314","title":"每日沽空追蹤 | 來凱醫藥-B 02月16日沽空量成交12.95萬股，沽空比例為11.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612343314","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612343314?lang=zh_tw&edition=fundamental","pubTime":"2026-02-16 16:30","pubTimestamp":1771230624,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月16日，涨2.89%，卖空量成交12.95万股，较上一交易日减少17.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163309a700ded2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163309a700ded2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2611508171","title":"每日沽空追蹤 | 來凱醫藥-B 02月13日沽空量成交11.6萬股，沽空比例為5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611508171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611508171?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 16:30","pubTimestamp":1770971428,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月13日，涨1.88%，卖空量成交11.6万股，较上一交易日减少30.95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163355a6f6e514&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163355a6f6e514&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2611150818","title":"來凱醫藥-B盤中異動 股價大漲5.15%報12.860港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611150818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611150818?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 11:48","pubTimestamp":1770954515,"startTime":"0","endTime":"0","summary":"2026年02月13日临近午盘11时48分，来凯医药-B股票出现异动，股价大幅上涨5.15%。截至发稿，该股报12.860港元/股，成交量70.95万股，换手率0.16%，振幅5.56%。资金方面，该股资金流入496.091万港元，流出324.781万港元。来凯医药-B股票所在的生物技术行业中，整体跌幅为1.32%。其相关个股中，再鼎医药、中国抗体-B、来凯医药-B涨幅较大，振幅较大的相关个股有北海康成-B、再鼎医药、中国抗体-B，振幅分别为10.45%、7.99%、7.82%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213114835a6f5ecef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213114835a6f5ecef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2610741826","title":"每日沽空追蹤 | 來凱醫藥-B 02月10日沽空量成交4.75萬股，沽空比例為3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610741826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610741826?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 16:30","pubTimestamp":1770712229,"startTime":"0","endTime":"0","summary":"来凯医药-B北京时间02月10日，涨2.11%，卖空量成交4.75万股，较上一交易日减少53.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163354a492ba7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163354a492ba7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2610697551","title":"來凱醫藥-B盤中異動 股價大漲5.11%報12.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610697551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610697551?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 10:38","pubTimestamp":1770691099,"startTime":"0","endTime":"0","summary":"2026年02月10日早盘10时38分，来凯医药-B股票出现异动，股价大幅拉升5.11%。截至发稿，该股报12.950港元/股，成交量53.8万股，换手率0.12%，振幅4.46%。资金方面，该股资金流入513.259万港元，流出103.209万港元。来凯医药-B股票所在的生物技术行业中，整体涨幅为2.76%。其相关个股中，宜明昂科-B、荣昌生物、歌礼制药-B涨幅较大，振幅较大的相关个股有帝王国际投资、泰格医药、旺山旺水-B，振幅分别为10.91%、7.71%、7.37%。LAE001是雄性激素合成抑制剂,可同时抑制CYP17A1及CYP11B2。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010381997a59056&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010381997a59056&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":156,"code":"91000000","status":"200"}]}}